SelfDecode uses the only scientifically validated genetic prediction technology for consumers. Read more
You exercise regularly, keep your cholesterol in check, and watch your sodium intake. Yet your family history haunts you. Your father had a stroke at 58. Your mother takes blood pressure medication despite a healthy lifestyle. You wonder if you’re on the same path. Standard medical tests come back reassuring. But something feels unfinished about that reassurance.
Written by the SelfDecode Research Team
✔️ Reviewed by a licensed physician
Stroke isn’t random. It’s not simply about lifestyle choices you failed to make. Stroke risk is encoded in your DNA, in six specific genes that control your blood clotting factors, cholesterol metabolism, blood pressure regulation, and nitric oxide production. You can do everything right and still carry the biological instructions for a cardiovascular event. Your standard lipid panel and blood pressure reading miss the real story. They measure the end result, not the genetic machinery that created it.
Most people think stroke prevention is about managing numbers you can see: cholesterol levels, blood pressure readings, weight. But the six genes that drive stroke risk operate at a level your doctor’s office never examines. One gene controls whether your blood clots too easily. Another determines how efficiently your body clears LDL cholesterol. A third regulates whether your blood vessels can dilate properly. You can lower your cholesterol 50 points and still have a Gene that makes you 4 times more likely to clot. That’s not failure. That’s biology.
This is why knowing your genetic risk matters. It rewrites the entire prevention strategy. Instead of generic advice, you get targeted interventions that address the specific biological malfunction your DNA created. For some people, that means a different blood pressure medication. For others, it means aggressive homocysteine management. For others still, it means understanding that their clotting risk requires a completely different approach.
Your cholesterol panel tells you your current LDL level. It does not tell you whether your APOE gene makes you inefficient at clearing LDL from your bloodstream. Your blood pressure reading tells you today’s number. It does not tell you whether your ACE gene makes your body more aggressive at raising and holding blood pressure. Your routine bloodwork cannot see the genes that control your clotting cascade, your nitric oxide production, or your lipoprotein(a) levels. These genetic variations sit quietly in your DNA, shaping your cardiovascular destiny, invisible to standard medicine.
Stroke happens when blood flow to your brain stops. That can happen two ways: a clot blocks an artery, or a weakened vessel ruptures. Your genes control all the machinery involved. Some genes govern whether your blood clots too easily. Others determine how your body handles cholesterol and whether arteries stay clean. Still others control blood pressure and how well your blood vessels can dilate to maintain flow. Your stroke risk is the sum of how your six key cardiovascular genes are wired. The good news: once you know which ones are working against you, you can intervene.
Rated 4.7/5 from 750+ reviews
200,000+ users, 2,000+ doctors & 100+ businesses
Already have 23andMe or AncestryDNA data? Get your report without a new kit — upload your file today.
Each of these genes plays a distinct role in preventing or promoting a cardiovascular event. Some affect clotting. Others affect cholesterol clearance or blood pressure. One controls nitric oxide production and blood vessel dilation. Together, they write your genetic predisposition to stroke. Below is what each one does, what your variant means, and what to do about it.
Your APOE gene produces a protein that packages cholesterol into particles your liver can clear from your blood. This is a critical function. When it works well, LDL cholesterol enters your cells, gets metabolized, and leaves your bloodstream. When it doesn’t work well, cholesterol builds up in your arterial walls, forming plaques that narrow blood vessels and increase stroke risk.
The APOE gene comes in three main variants: e2, e3, and e4. If you carry the e4 allele, roughly 25% of people of European ancestry carry at least one copy, your cholesterol metabolism is less efficient. The e4 variant reduces your body’s ability to clear LDL from your blood and increases your cardiovascular and dementia risk. This is not about eating more salad. Your cells are literally less good at the job of moving cholesterol out.
What this means day-to-day: You might keep your cholesterol low through diet and exercise, and it still creeps back up. You might feel puzzled when your doctor says your numbers are okay but your family history is concerning. You might need more aggressive cholesterol management than your age or typical risk profile would suggest. Your body is simply not designed to clear LDL as efficiently as someone with the e2 or e3 variants.
People with APOE e4 often respond better to statins than to diet alone, and may benefit from additional lipid management strategies like PCSK9 inhibitors if standard treatment doesn’t achieve target LDL levels.
Your MTHFR gene controls an enzyme that sits at a critical junction in your body’s methylation cycle. This cycle is responsible for processing homocysteine, a byproduct of protein metabolism. If homocysteine clears efficiently, it poses no problem. If it accumulates, it damages the inner lining of your blood vessels, promotes inflammation, and dramatically increases clot formation and stroke risk.
The MTHFR C677T variant, which roughly 40% of people of European ancestry carry, reduces the enzyme’s efficiency by 40 to 70 percent. This means your cells convert folate and B12 into their active forms more slowly, and homocysteine lingers in your bloodstream longer. Even if your standard homocysteine blood test comes back normal, you may be clearing it at the margin of safety.
What this means day-to-day: You can take regular B vitamins and feel no improvement because they are not being converted into the active forms your methylation cycle needs. You might feel fatigued or foggy despite good nutrition. You might have unexplained inflammation. Most importantly, your elevated homocysteine is silently damaging your arteries, increasing your stroke risk in a way that standard blood pressure and cholesterol management misses.
People with MTHFR C677T variants typically need methylated B vitamins (methylfolate and methylcobalamin, not standard folic acid) to effectively lower homocysteine and reduce vascular damage.
Your ACE gene codes for angiotensin-converting enzyme, a protein that creates angiotensin II, a molecule that constricts blood vessels and raises blood pressure. This system exists for a reason: it helps maintain blood flow during physical stress or blood loss. But when it’s overactive, it becomes a stroke risk factor.
The ACE I/D polymorphism determines how much ACE enzyme your body makes. If you carry the D/D genotype, roughly 25% of the population, your body produces more ACE and more angiotensin II. This means your blood vessels constrict more aggressively, your resting blood pressure runs higher, and your risk of cardiac hypertrophy and stroke increases. Your body is biologically wired to run hot.
What this means day-to-day: Your blood pressure may creep up despite exercise and low sodium intake. You may need medication earlier than your peers. You might respond better to certain classes of blood pressure drugs (ACE inhibitors or angiotensin receptor blockers) than to others. You are not lazy or undisciplined. Your genetic wiring simply favors higher baseline pressure.
People with ACE D/D genotypes often see the best results with ACE inhibitors or ARB medications, which directly counteract their over-active angiotensin II system.
Your NOS3 gene produces nitric oxide synthase, an enzyme that makes nitric oxide. Nitric oxide is a signaling molecule that tells your blood vessel walls to relax and dilate, allowing blood to flow freely. This is crucial. When your arteries can dilate, blood pressure stays normal and clots are less likely to form. When they cannot, pressure rises and flow becomes turbulent.
The NOS3 Glu298Asp variant, carried by 30 to 40 percent of the population, reduces nitric oxide production. Your blood vessels lose their ability to dilate efficiently, blood pressure climbs, and atherosclerotic plaques are more likely to form. You are essentially running on a system with reduced shock absorbers.
What this means day-to-day: Your blood pressure may be consistently higher than your peers despite similar exercise and diet. You might notice poor exercise tolerance or get winded more easily. You might experience blood vessel stiffness, especially as you age. You might respond poorly to vasodilating nutrients like L-citrulline or beetroot juice because the underlying problem is not nutrition, it’s enzyme expression.
People with NOS3 variants often benefit from lifestyle factors that boost nitric oxide naturally: regular aerobic exercise, L-arginine or L-citrulline supplementation, and beet juice, which contains inorganic nitrate that your body can convert to nitric oxide.
Your F5 gene codes for Factor V, a clotting protein that is essential for stopping bleeding when you cut yourself. But clotting is a delicate balance. Too little, and you bleed easily. Too much, and blood clots where it should not, blocking blood vessels and causing stroke or deep vein thrombosis.
The Factor V Leiden variant (R506Q), carried by roughly 5% of people of European ancestry, makes Factor V resistant to being shut down. This means your blood clots 4 to 8 times more readily than normal, and if you use oral contraceptives, your clotting risk jumps 80-fold. You are biologically primed to form clots in your veins and arteries.
What this means day-to-day: You have a significantly elevated risk of stroke, especially if you are female and using hormonal contraception. You might develop unexplained blood clots in your legs or lungs. You might have a family history of young people experiencing strokes or clots. You should never assume a clot is coincidence. Your genetic predisposition makes clotting your baseline state.
People with Factor V Leiden must avoid oral contraceptives (which multiply their clotting risk 80-fold), may need anticoagulation therapy, and should be especially vigilant about immobility during long flights or hospital stays.
Your LPA gene controls your lipoprotein(a) levels, a type of lipoprotein particle structurally similar to LDL cholesterol but genetically determined. Unlike LDL, which you can lower with diet and exercise, Lp(a) is almost entirely under genetic control. Your level is set at birth and remains stable throughout your life. This is important because elevated Lp(a) is an independent risk factor for heart attack and stroke.
Roughly 20% of the population carries genetic variants that produce elevated lipoprotein(a) levels. High Lp(a) increases your cardiovascular risk independently of cholesterol, blood pressure, or any lifestyle factor. You can have perfect cholesterol, perfect blood pressure, perfect fitness, and still carry a genetic predisposition to arterial damage from Lp(a) buildup.
What this means day-to-day: Your standard lipid panel might not even measure your Lp(a), so you could be at risk without knowing it. You might have family members who suffered strokes or heart attacks despite perfect risk factor management. Standard preventive strategies will not lower your Lp(a) because it is genetically hardwired. You need targeted strategies to address it specifically.
People with elevated Lp(a) may benefit from lipoprotein apheresis (a blood filtration procedure), certain statins at higher doses, PCSK9 inhibitors, or newer Lp(a)-lowering therapies like periphrdin, which specifically targets this lipoprotein.
Most people see themselves in multiple genes. That is normal. Your stroke risk is the sum of all six. Your APOE variant might be pushing your cholesterol up. Your ACE variant might be pushing your blood pressure up. Your NOS3 variant might be impairing your blood vessel function. Your F5 variant might be making you prone to clots. The question is: which combination is your unique stroke profile? And more importantly, which interventions will work best for your specific genetic wiring? You cannot know by guessing. The interventions that work for elevated cholesterol (statins) are different from those that work for elevated clotting risk (anticoagulation or lifestyle modification). The strategies that lower blood pressure do not lower Lp(a). You need to know your specific genetic drivers to prevent your specific risk.
❌ Taking a statin aggressively when you have elevated Lp(a) might lower your LDL but will not lower your Lp(a), leaving your true cardiovascular risk unaddressed. You need Lp(a)-specific therapies.
❌ Taking standard folic acid when you have MTHFR C677T will not effectively lower your homocysteine because your cells cannot convert regular folic acid into its active form. You need methylated folate.
❌ Taking a generic ACE inhibitor when you have Factor V Leiden might manage your blood pressure but does nothing to address your dramatically elevated clotting risk. You need anticoagulation or lifestyle strategies that reduce clot formation.
❌ Relying on exercise and weight loss when you have NOS3 variants will not restore your blood vessels’ ability to dilate because the problem is enzyme expression, not fitness. You need nitric oxide-boosting interventions targeted at that specific pathway.
This is why the personalization matters. Not as a marketing angle — as a biological necessity. The path to actually resolving this starts with knowing what you’re working with.
A DNA test won’t tell you everything. But for symptoms with a genetic root cause, it’s the only test that actually gets to the source. Here’s the path from confusion to clarity.
View our sample report, just one of over 1500 personalized insights waiting for you. With SelfDecode, you get more than a static PDF; you unlock an AI-powered health coach, tools to analyze your labs and lifestyle, and access to thousands of tailored reports packed with actionable recommendations.
I was terrified after my father had a stroke at 62. My cholesterol and blood pressure were normal, but I felt like I was sitting on a time bomb. My cardiologist kept telling me there was nothing wrong. My DNA report showed I carry APOE e4, ACE D/D, and Factor V Leiden. That changed everything. I switched to a statin even though my cholesterol was normal, started methylated B vitamins for homocysteine management, and my doctor prescribed a low-dose anticoagulant because of my clotting risk. My cardiologist was stunned when I told him my genetic profile. He said my standard tests would never have caught this. Six months later, I got a stress test and my cardiac flow is excellent. For the first time since my father’s stroke, I feel like I am doing something that actually addresses my real risk.
Start with the report most relevant to your issue, or unlock the full picture of everything your DNA can tell you. Either way, one kit covers you for life — we analyze your DNA once, and every new report is generated from the same sample.
30-Days Money-Back Guarantee*
Shipping Worldwide
US & EU Based Labs & Shipping
SelfDecode DNA Kit Included
HSA & FSA Eligible
HSA & FSA Eligible
SelfDecode DNA Kit Included
HSA & FSA Eligible
SelfDecode DNA Kit Included
+ Free Consultation
* SelfDecode DNA kits are non-refundable. If you choose to cancel your plan within 30 days you will not be refunded the cost of the kit.
We will never share your data
We follow HIPAA and GDPR policies
We have World-Class Encryption & Security
Rated 4.7/5 from 750+ reviews
200,000+ users, 2,000+ doctors & 100+ businesses
Yes. Multiple large studies show that APOE e4, F5 Leiden, elevated Lp(a), and variants in blood pressure genes like ACE and NOS3 are strong independent predictors of cardiovascular events. These genes do not guarantee a stroke, but they shift the odds significantly. The key is that these genes control biological pathways your doctor’s standard tests do not measure. Your lipid panel tells you your current cholesterol level. It does not tell you whether your APOE e4 is making it harder for your body to clear that cholesterol. Your blood pressure reading tells you today’s number. It does not tell you whether your ACE D/D genotype is biologically wired to run high. The genes provide the missing context.
Yes. If you have already done a 23andMe or AncestryDNA test, you can upload your raw DNA data to SelfDecode. The analysis takes just a few minutes and gives you immediate access to your cardiovascular genetic profile without needing a second test. If you have not tested yet, SelfDecode’s DNA kit uses the same gold-standard genotyping technology and comes with comprehensive genomic analysis across all your health pathways.
Significantly. If you have MTHFR C677T, you need methylfolate and methylcobalamin, not standard folic acid or cyanocobalamin. If you have elevated Lp(a), certain statins and newer drugs like periphrdin are more effective than older ones. If you have NOS3 variants, you may benefit from L-arginine or L-citrulline at specific dosages rather than exercise alone. If you have ACE D/D, ACE inhibitors and ARBs are often more effective than other blood pressure classes. If you have Factor V Leiden, you may need anticoagulation therapy or specific lifestyle modifications to reduce clot risk. The point is that generic supplements and medications miss your specific genetic needs. Your report tells you exactly which forms and doses are most likely to work for you.
SelfDecode is a personalized health report service, which enables users to obtain detailed information and reports based on their genome. SelfDecode strongly encourages those who use our service to consult and work with an experienced healthcare provider as our services are not to replace the relationship with a licensed doctor or regular medical screenings.